- Gus Cairns | 07 April 2011
Grant P et al. Association of Baseline Viral Load, CD4
Count, and Week 4 Virologic Response with Virologic Failure in ACTG Study A5202.
Eighteenth Conference on Retroviruses and Opportunistic Infections, Boston, abstract ...
- Gus Cairns | 29 March 2011
Very high levels of adherence have been achieved in one of
the ongoing randomised controlled trials of oral pre-exposure prophylaxis
(PrEP), according to a poster presentation at last month’s Conference on Retroviruses ...
- Gus Cairns | 25 March 2011
The San Francisco study presented an apparently
very different pattern of behaviour. This study counted the number of partners
men had had in the previous three months. This was ten at diagnosis ...
- Keith Alcorn | 10 March 2011
Lambers F et al. High incidence rate of HCV reinfection
after treatment of acute HCV infection in HIV-infected MSM in Amsterdam. Eighteenth Conference on
Retroviruses and Opportunistic Infections, Boston, abstract 958, 2011.
...
- Gus Cairns | 09 March 2011
You can view the abstracts from this research on the official conference
website:
Abstract 1022 and the PDF of the poster: http://www.retroconference.org/2011/Abstracts/41808.htm
Abstract 483: http://www.retroconference.org/2011/Abstracts/40183.htm
Abstract 484: http://www.retroconference.org/2011/Abstracts/42134.htmAbstract 486: http://www.retroconference.org/2011/Abstracts/41978.htmYou can also view a ...
-
Gus Cairns | 09 March 2011
You
can view the abstracts and posters from this research on the official conference website:Abstract 508: See the abstract here and
poster here.Abstract 1024: See the
abstract here
and poster here.You can also view ...
- Keith Alcorn | 07 March 2011
Desvarieux M et al. Carotid atherosclerosis is related to HIV duration
and anti-inflammatory profile and not to ARV exposure: the CHIC controlled
study. Eighteenth Conference on Retroviruses and Opportunistic Infections, Boston, abstract ...
- Carole Leach-Lemens | 07 March 2011
Infant
treatment is complicated by exposure to single-dose nevirapine after
delivery; infants who become infected despite prophylaxis have a high
risk of acquiring nevirapine-resistant virus.
Infant
treatment with a nevirapine-containing antiretroviral regimen may
result in treatment ...
- Carole Leach-Lemens | 07 March 2011
Extending the use of daily infant nevirapine to six months reduced the risk of
breastfeeding mother-to-child transmission by a significant 76% in
HIV-positive mothers with CD4 cell counts over 350 and not ...
-
Gus Cairns | 03 March 2011 Having said this, viral load in semen and vaginal fluids probably
influences the risk of transmission more than blood plasma viral load. Jared
Baeten, also from UWS, presented a substudy of 2521 ...
- Gus Cairns | 03 March 2011
You can view the abstracts from this research on the official conference
website:
Abstract 37LB: www.retroconference.org/2011/Abstracts/42531.htm
Abstract 99LB: www.retroconference.org/2011/Abstracts/42617.htmYou can also watch webcasts of these presentations. Abstract 37LB was presented by Ji-Eun Park ...
- Gus Cairns | 03 March 2011
Abbas U et al. Predicting the Impact of ART and PrEP with
Overlapping Regimens on HIV Transmission and Drug Resistance in South Africa.
Eighteenth Conference on Retroviruses and Opportunistic Infections, Boston. Abstract
98LB. ...
- Liz Highleyman | 03 March 2011
Eron
J et al. QDMRK,
a phase III study of the safety and efficacy of once daily vs twice
daily RAL in combination therapy for treatment-naive HIV-infected
patients. 18th
Conference on Retroviruses and Opportunistic Infections, ...
- Keith Alcorn | 03 March 2011
Signals warning of the
transmission of drug-resistant HIV are growing in low- and
middle-income countries, and governments should step up surveillance
efforts as they scale up treatment, experts concluded today at the
Eighteenth Conference ...
- Liz Highleyman | 02 March 2011
You can view the abstracts from this research on the official conference
website:
Abstract 146LB: http://www.retroconference.org/2011/Abstracts/42467.htm
You can also watch a webcast, see the slides or listen to an audio mp3 of the ...
- Gus Cairns | 02 March 2011
You can view the abstract from this research on the official conference
website:
Abstract 35LB: http://www.retroconference.org/2011/Abstracts/42418.htmYou can also watch a webcast of the presentations made at this conference
session.
Webcast from HIV Prevention: ...
- Liz Highleyman | 02 March 2011
Immune recovery and T-cell restoration may play a key role in bone loss
that occurs very soon after starting antiretroviral therapy, according to a
small study presented on Tuesday at the
18th Conference ...
- Gus Cairns | 02 March 2011
One
concern in trials using tenofovir as post-exposure prophylaxis has been that
all antiretrovirals seem to cause a transient loss in bone mineral density, but
that this seems to be larger and in ...
- Keith Alcorn | 02 March 2011
The US Food and Drug
Administration has found no evidence of an association between
abacavir treatment and increased risk of myocardial infarction (heart
attack) in a meta-analysis of 26 randomised trials of the ...
- Liz Highleyman | 02 March 2011
HIV-positive people who lose muscle mass in their arms and legs whilst
gaining abdominal fat have a higher likelihood of death, according to
findings from the FRAM study presented on Tuesday at
the ...
Talking points: a checklist for you and your doctorTalking points is designed to help you talk to your doctor about HIV
treatment.
Preventing HIVAn essential resource providing evidence-based information on preventing HIV infection. 
HIV, stigma and discrimination is now available in print!17 May 2012This week, boxes of the brand-new edition of our booklet...
Come and see us at the BHIVA conference!18 April 2012This morning, I boarded a train at Euston with one...
Community action on harm reduction (CAHR)16 April 2012We’ve been working on the design and
development of a new...